Annual Revenue
$57.42 M
+$6.08 M+11.84%
December 31, 2023
Summary
- As of February 8, 2025, TBPH annual revenue is $57.42 million, with the most recent change of +$6.08 million (+11.84%) on December 31, 2023.
- During the last 3 years, TBPH annual revenue has fallen by -$14.43 million (-20.09%).
- TBPH annual revenue is now -55.88% below its all-time high of $130.15 million, reached on December 31, 2012.
Performance
TBPH Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$16.87 M
+$2.61 M+18.32%
September 30, 2024
Summary
- As of February 8, 2025, TBPH quarterly revenue is $16.87 million, with the most recent change of +$2.61 million (+18.32%) on September 30, 2024.
- Over the past year, TBPH quarterly revenue has increased by +$1.18 million (+7.49%).
- TBPH quarterly revenue is now -42.82% below its all-time high of $29.50 million, reached on December 31, 2019.
Performance
TBPH Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$63.19 M
+$1.18 M+1.89%
September 30, 2024
Summary
- As of February 8, 2025, TBPH TTM revenue is $63.19 million, with the most recent change of +$1.18 million (+1.89%) on September 30, 2024.
- Over the past year, TBPH TTM revenue has increased by +$8.68 million (+15.93%).
- TBPH TTM revenue is now -28.14% below its all-time high of $87.94 million, reached on March 31, 2020.
Performance
TBPH TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TBPH Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.8% | +7.5% | +15.9% |
| 3 y3 years | -20.1% | +27.9% | +6.9% |
| 5 y5 years | -4.9% | -9.9% | -12.1% |
TBPH Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +11.8% | -4.0% | +61.9% | at high | +30.1% |
| 5 y | 5-year | -21.8% | +11.8% | -42.8% | +61.9% | -28.1% | +30.1% |
| alltime | all time | -55.9% | >+9999.0% | -42.8% | >+9999.0% | -28.1% | >+9999.0% |
Theravance Biopharma Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $16.87 M(+18.3%) | $63.19 M(+1.9%) |
| Jun 2024 | - | $14.26 M(-1.7%) | $62.02 M(+0.8%) |
| Mar 2024 | - | $14.50 M(-17.4%) | $61.51 M(+7.1%) |
| Dec 2023 | $57.42 M(+11.8%) | $17.57 M(+11.9%) | $57.42 M(+5.3%) |
| Sep 2023 | - | $15.69 M(+14.1%) | $54.51 M(+6.3%) |
| Jun 2023 | - | $13.75 M(+32.0%) | $51.27 M(+5.6%) |
| Mar 2023 | - | $10.42 M(-28.9%) | $48.57 M(-5.4%) |
| Dec 2022 | $51.35 M(-7.2%) | $14.65 M(+17.7%) | $51.35 M(-0.6%) |
| Sep 2022 | - | $12.45 M(+12.7%) | $51.64 M(-1.4%) |
| Jun 2022 | - | $11.05 M(-16.3%) | $52.39 M(-3.4%) |
| Mar 2022 | - | $13.20 M(-11.7%) | $54.25 M(-1.9%) |
| Dec 2021 | $55.31 M(-23.0%) | $14.95 M(+13.3%) | $55.31 M(-6.4%) |
| Sep 2021 | - | $13.19 M(+2.2%) | $59.09 M(-7.9%) |
| Jun 2021 | - | $12.91 M(-9.4%) | $64.16 M(-3.2%) |
| Mar 2021 | - | $14.26 M(-23.9%) | $66.25 M(-7.8%) |
| Dec 2020 | $71.86 M(-2.1%) | $18.73 M(+2.6%) | $71.86 M(-13.0%) |
| Sep 2020 | - | $18.26 M(+21.6%) | $82.63 M(+7.6%) |
| Jun 2020 | - | $15.01 M(-24.4%) | $76.80 M(-12.7%) |
| Mar 2020 | - | $19.86 M(-32.7%) | $87.94 M(+19.8%) |
| Dec 2019 | $73.41 M(+21.6%) | $29.50 M(+137.4%) | $73.41 M(+23.1%) |
| Sep 2019 | - | $12.43 M(-52.5%) | $59.65 M(-0.7%) |
| Jun 2019 | - | $26.15 M(+389.9%) | $60.06 M(+4.7%) |
| Mar 2019 | - | $5.34 M(-66.1%) | $57.39 M(-4.9%) |
| Dec 2018 | $60.37 M | $15.74 M(+22.6%) | $60.37 M(+22.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $12.84 M(-45.3%) | $49.15 M(+21.1%) |
| Jun 2018 | - | $23.48 M(+182.2%) | $40.59 M(+96.8%) |
| Mar 2018 | - | $8.32 M(+84.3%) | $20.62 M(+34.0%) |
| Dec 2017 | $15.39 M(-68.4%) | $4.51 M(+5.6%) | $15.39 M(-7.1%) |
| Sep 2017 | - | $4.28 M(+21.8%) | $16.56 M(-47.2%) |
| Jun 2017 | - | $3.51 M(+13.7%) | $31.36 M(-5.9%) |
| Mar 2017 | - | $3.09 M(-45.8%) | $33.33 M(-31.5%) |
| Dec 2016 | $48.65 M(+15.5%) | $5.69 M(-70.2%) | $48.65 M(+3.8%) |
| Sep 2016 | - | $19.07 M(+248.7%) | $46.85 M(+21.8%) |
| Jun 2016 | - | $5.47 M(-70.3%) | $38.47 M(-4.1%) |
| Mar 2016 | - | $18.41 M(+372.9%) | $40.13 M(-4.7%) |
| Dec 2015 | $42.13 M(+260.4%) | $3.89 M(-63.6%) | $42.13 M(+6.2%) |
| Sep 2015 | - | $10.70 M(+50.0%) | $39.67 M(+12.4%) |
| Jun 2015 | - | $7.13 M(-65.0%) | $35.30 M(+13.4%) |
| Mar 2015 | - | $20.40 M(+1323.7%) | $31.14 M(+166.5%) |
| Dec 2014 | $11.69 M(+5071.7%) | $1.43 M(-77.4%) | $11.69 M(+12.1%) |
| Sep 2014 | - | $6.34 M(+113.0%) | $10.43 M(+153.3%) |
| Jun 2014 | - | $2.97 M(+214.7%) | $4.12 M(+258.4%) |
| Mar 2014 | - | $945.00 K(+440.0%) | $1.15 M(+408.4%) |
| Dec 2013 | $226.00 K(-99.8%) | $175.00 K(+629.2%) | $226.00 K(+343.1%) |
| Sep 2013 | - | $24.00 K(+380.0%) | $51.00 K(+88.9%) |
| Jun 2013 | - | $5000.00(-77.3%) | $27.00 K(+22.7%) |
| Mar 2013 | - | $22.00 K | $22.00 K |
| Dec 2012 | $130.15 M | - | - |
FAQ
- What is Theravance Biopharma annual revenue?
- What is the all time high annual revenue for Theravance Biopharma?
- What is Theravance Biopharma annual revenue year-on-year change?
- What is Theravance Biopharma quarterly revenue?
- What is the all time high quarterly revenue for Theravance Biopharma?
- What is Theravance Biopharma quarterly revenue year-on-year change?
- What is Theravance Biopharma TTM revenue?
- What is the all time high TTM revenue for Theravance Biopharma?
- What is Theravance Biopharma TTM revenue year-on-year change?
What is Theravance Biopharma annual revenue?
The current annual revenue of TBPH is $57.42 M
What is the all time high annual revenue for Theravance Biopharma?
Theravance Biopharma all-time high annual revenue is $130.15 M
What is Theravance Biopharma annual revenue year-on-year change?
Over the past year, TBPH annual revenue has changed by +$6.08 M (+11.84%)
What is Theravance Biopharma quarterly revenue?
The current quarterly revenue of TBPH is $16.87 M
What is the all time high quarterly revenue for Theravance Biopharma?
Theravance Biopharma all-time high quarterly revenue is $29.50 M
What is Theravance Biopharma quarterly revenue year-on-year change?
Over the past year, TBPH quarterly revenue has changed by +$1.18 M (+7.49%)
What is Theravance Biopharma TTM revenue?
The current TTM revenue of TBPH is $63.19 M
What is the all time high TTM revenue for Theravance Biopharma?
Theravance Biopharma all-time high TTM revenue is $87.94 M
What is Theravance Biopharma TTM revenue year-on-year change?
Over the past year, TBPH TTM revenue has changed by +$8.68 M (+15.93%)